Record-Breaking Revenue Growth
For the fiscal year ended March 31, 2025, Beyond Air reported a 220% increase in revenue to $3.7 million compared with $1.2 million for the same period last year.
Strong Revenue Guidance
The company provided revenue guidance of $12 million to $16 million for the full fiscal year ending March 31, 2026, indicating sustained high growth.
Expansion into International Markets
Beyond Air has expanded its commercial program across Europe, Southeast Asia, and the Middle East, signing distribution agreements in over two dozen countries.
FDA Submission for Next-Generation Device
Beyond Air submitted a PMA supplement for LungFit PH II, a smaller, lighter, and more transportable version of the current FDA-approved system.
Notable Partnerships and Recognition
Beyond Air partnered with Vanderbilt University Medical Center as the first luminary site for LungFit PH and announced the appointment of Bob Goodman to its Board of Directors.